OMAH Delivers 15% Returns While Berkshire Stock Drops 5%: The Buffett ETF Retirees Overlook

OMAH is an actively managed ETF designed to address the lack of dividends from Berkshire Hathaway by generating cash distributions for shareholders. The fund holds about 21 positions modeled on Berkshire’s publicly disclosed equity portfolio, including major holdings such as Apple and Bank of America. It uses a two-part strategy: a core equity sleeve to capture upside from Buffett-style stock picks and a covered-call overlay that sells short-term options against those holdings. The options premium is used to fund monthly distributions. The fund targets a 15% annualized yield, and its monthly payouts have remained consistent, with recent per-share distributions staying within a narrow range.

"At its core, OMAH is an actively managed ETF holding roughly 21 positions drawn from Berkshire Hathaway itself and the largest stakes in its 13F filings, including Apple ( NASDAQ:AAPL) and Bank of America ( NYSE:BAC), as well as other Buffett staples. The expense ratio is 0.95%, well above a plain index fund but in line with other covered call products."

"This specialized investment engine relies on two distinct components. The core equity sleeve captures direct upside from Warren Buffett's signature stock picks, while a programmatic covered-call overlay systematically sells short-term options against those core holdings to extract cash premium. Those recurring options gains directly bankroll the fund's monthly shareholder distributions."

"Its stated mandate targets a 15% annualized yield, which converts a $50,000 principal position into roughly $7,500 in annual liquidity, distributed as 12 scheduled payments. Does the income show up? This steady monthly distribution cadence remains entirely unbroken."

"OMAH successfully distributed $0.23225 per share in April 2026, $0.22688 during March, and $0.23088 for February, sustaining a highly consistent payout sequence that fluctuated tightly between $0.22 and $0.25 throughout the prior year. Annualized against a prevailing $19 market price,"

Read at 24/7 Wall St.